GIUGLIANO, FEDERICA
GIUGLIANO, FEDERICA
Dipartimento di Oncologia ed Emato-Oncologia
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies
2025 F. Giugliano, C. De Angelis, B. Pistilli, G. Viale, G. Bianchini, M. Giuliano, L. Malorni, B. Taurelli Salimbeni, A. Esposito, A. Giordano, T.A. Yap, G. Curigliano, C. Criscitiello
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology
2025 F. Giugliano, E. Giordano, L. Gilardi, B.T. Salimbeni, P. Zagami, A. Esposito, A. Marra, D. Trapani, P.P.M. Berton Giachetti, B. Malagutti, T. Henry, D. Deandreis, G. Curigliano, F. Ceci, C. Criscitiello
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
2024 E. Agostinetto, M. Bruzzone, A. Hamy, H.J. Kim, C. Chiodi, R. Bernstein-Molho, S. Linn, K. Pogoda, E. Carrasco, F. Derouane, J. Bajpai, G. Nader-Marta, N. Lopetegui-Lia, A.H. Partridge, L. Cortesi, C. Rousset-Jablonski, F. Giugliano, T. Renaud, A. Ferrari, S. Paluch-Shimon, R. Fruscio, W. Cui, S.M. Wong, C. Vernieri, K.J. Ruddy, M.V. Dieci, A. Matikas, M. Rozenblit, D. Aguilar Y Mendez, L. De Marchis, R. Borea, F. Puglisi, M. Pistelli, J. Kufel-Grabowska, R. Di Rocco, E. Mariamidze, F. Atzori, H.R. Kourie, L. Popovic, E. de Azambuja, E. Blondeaux, M. Lambertini
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
2024 E. Nicolò, S. Gandini, F. Giugliano, J. Uliano, O. D'Ecclesiis, S. Morganti, E. Ferraro, D. Trapani, P. Tarantino, P. Zagami, L. Boldrini, I. Caramella, A. Carnevale Schianca, M. Cristofanilli, M.A. Locatelli, A. Esposito, C. Belli, I. Minchella, C. Criscitiello, A. Marra, G. Curigliano
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
2024 L. Mazzarella, F. Giugliano, E. Nicolo, A. Esposito, E. Crimini, G. Tini, J. Uliano, C. Corti, P. D'Amico, P.T. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P.P.M. Berton Giachetti, I. Minchella, C. Belli, M. Locatelli, C. Criscitiello, G. Curigliano
PARP Inhibitors for Breast Cancer Treatment
2024 S. Morganti, A. Marra, C. De Angelis, A. Toss, L. Licata, F. Giugliano, B. Taurelli Salimbeni, P.P.M. Berton Giachetti, A. Esposito, A. Giordano, G. Bianchini, E. Garber Judy, G. Curigliano, F. Lynce, C. Criscitiello
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
2023 E. Nicolò, P. Tarantino, O. D'Ecclesiis, G. Antonarelli, L. Boscolo Bielo, A. Marra, S. Gandini, E. Crimini, F. Giugliano, P. Zagami, C. Corti, D. Trapani, S. Morganti, C. Criscitiello, M. Locatelli, C. Belli, A. Esposito, I. Minchella, M. Cristofanilli, S.M. Tolaney, G. Curigliano
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
HER2-Low Breast Cancer: a New Subtype?
2023 C. Corti, F. Giugliano, E. Nicolò, P. Tarantino, C. Criscitiello, G. Curigliano
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases
2023 P. Trillo, J. Sandoval, D. Trapani, E. Nicolò, P. Zagami, F. Giugliano, P. Tarantino, G. Vivanet, L. Ascione, A. Friedlaender, A. Esposito, C. Criscitiello, G. Curigliano
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
2023 S. Morganti, A. Marra, S. Gandini, L. Ascione, M. Ivanova, K. Venetis, E. Sajjadi, P. Zagami, F. Giugliano, B. Taurelli Salimbeni, P.P.M. Berton Giachetti, C. Corti, E. De Camilli, G. Curigliano, N. Fusco, C. Criscitiello
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution
2023 F. Giugliano, A. Carnevale Schianca, C. Corti, M. Ivanova, N. Bianco, S. Dellapasqua, C. Criscitiello, N. Fusco, G. Curigliano, E. Munzone
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population
2022 L. Mazzarella, F. Giugliano, E. Nicolo', E. Crimini, J. Uliano, C. Corti, P. D'Amico, P. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P. Giachetti, I. Minchella, C. Belli, A. Esposito, M. Locatelli, C. Criscitiello, G. Curigliano
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
2022 F. Giugliano, P.A. Zucali, G. Galli, Z. Ballatore, C. Corti, P.T. Aliaga, J. Uliano, G. Vivanet, G. Curigliano, F. Conforti, P. Queirolo, R. Berardi, S. Manglaviti, G. Apollonio, M. Perrino, F. Borea, F. D'Antonio, M.C. Garassino, T. De Pas
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
2022 E. Nicolò, F. Giugliano, L. Ascione, P. Tarantino, C. Corti, S.M. Tolaney, M. Cristofanilli, G. Curigliano
Bystander effect of antibody-drug conjugates: fact or fiction?
2022 F. Giugliano, C. Corti, P. Tarantino, F. Michelini, G. Curigliano
Evolution of low HER2 expression between early and advanced-stage breast cancer
2022 P. Tarantino, S. Gandini, E. Nicolo, P. Trillo, F. Giugliano, P. Zagami, G. Vivanet, F. Bellerba, D. Trapani, A. Marra, A. Esposito, C. Criscitiello, G. Viale, G. Curigliano
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents
2022 P. Tarantino, O. D'Ecclesiis, E. Nicolò, G. Antonarelli, L. Boscolo Bielo, A. Marra, S. Gandini, E. Crimini, F. Giugliano, P. Zagami, C. Corti, D. Trapani, S. Morganti, C. Criscitiello, M.A. Locatelli, C. Belli, A. Esposito, I. Minchella, S.M. Tolaney, G. Curigliano
Harmonizing PD-L1 testing in metastatic triple negative breast cancer
2022 F. Giugliano, G. Antonarelli, P. Tarantino, J. Cortes, H.S. Rugo, G. Curigliano
Systemic Treatment of Ductal Carcinoma In Situ of the Breast
2021 E. Crimini, C. Corti, M. Repetto, F. Giugliano, G. Antonarelli, P. Tarantino, P. Zagami, S. Morganti, E. Nicolo, J. Uliano, G. Curigliano